SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.910-5.2%Dec 17 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DeadHead who wrote (7301)10/30/1997 12:08:00 PM
From: Leslie S. Feinberg  Read Replies (1) of 14328
 
Gordon: The results reported today are not "Fab". At the same time, we have been told that analysts projections for the year are $.07. That means performance for the 4th Q won't have to be a whole lot better to make those marks. I don't think there is much here to be surprised at either way. Looks like the company is grinding toward the goal of building a solid profitable company. Along the way they have hugely increased and improved both the physical plant and distribution pathways, digested two large acquisitions and managed to make a little profit at the same time. This next year will no doubt see the Uni-gold tests start to receive FDA approval, volumes of sales will pick up as the newly consolidated components of the company reach their potential synergy, and profits and stock price should be sharply higher. Oh yeah, IMHO. El Scripto
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News